The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for ME Sobhia


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors.EBI
National Institute of Pharmaceutical Education and Research (NIPER)
Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives.EBI
University of Hyderabad
Three-dimensional quantitative structure (3-D QSAR) activity relationship studies on imidazolyl and N-pyrrolyl heptenoates as 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibitors by comparative molecular similarity indices analysis (CoMSIA).EBI
National Institute of Pharmaceutical Education and Research (NIPER)
QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.EBI
National Institute of Pharmaceutical Education and Research (NIPER)
Probing the structural and topological requirements for CCR2 antagonism: holographic QSAR for indolopiperidine derivatives.EBI
National Institute of Pharmaceutical Education and Research (NIPER)
Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.EBI
National Institute of Pharmaceutical Education and Research (NIPER)